Pfizer Inc. and Moderna, Inc. appreciate the support they have received from the government in launching their COVID-19 vaccines, but do not seem eager for the Biden Administration to expand use of the Defense Production Act to increase their supply.
At a 23 February hearing of the Energy & Commerce Committee’s Subcommittee on Oversight and Investigation, executives from Pfizer and Moderna were
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?